Literature DB >> 17550936

Spirometry utilization for COPD: how do we measure up?

Meilan K Han1, Min Gayles Kim, Russell Mardon, Phil Renner, Sean Sullivan, Gregory B Diette, Fernando J Martinez.   

Abstract

BACKGROUND: COPD is a significant cause of morbidity and mortality. Guidelines recommend the confirmation of a COPD diagnosis with spirometry. Limited evidence exists, however, documenting the frequency of spirometry use in clinical practice.
METHODS: The National Committee for Quality Assurance recruited five health plans to determine the proportion of patients >/= 40 years old with a new diagnosis of COPD who had received spirometry during the interval starting 720 days prior to diagnosis and ending 180 days after diagnosis. Patients were identified via International Classification of Diseases, Ninth Revision diagnostic codes for encounters during the period July 1, 2002, through June 30, 2003. For each patient, the participating plans provided patient demographic and claims data from administrative data systems.
RESULTS: Participating health plans covered 1,597,749 members with a total of 5,039 eligible COPD patients identified. Patients in the 40 to 64 age range had the highest percentage of new COPD diagnoses. Women were also slightly more likely to undergo spirometry (33.5% vs 29.4%, p = 0.001). Approximately 32% of patients with a new diagnosis of COPD had undergone spirometry in the specified interval. Spirometry frequency was lowest in older patients, with the lowest frequency in those >/= 75 years old.
CONCLUSIONS: Our study suggests that approximately 32% of a broad range of patients with a new COPD diagnosis had undergone spirometry within the previous 2 years to 6 months following diagnosis. In addition, spirometric testing appeared to decrease with increasing age. As opposed to a prior report, women were not less likely to have undergone spirometry. This study shows that spirometry is infrequently used in clinical practice for diagnosis of COPD and suggests opportunities for practice improvement.

Entities:  

Mesh:

Year:  2007        PMID: 17550936     DOI: 10.1378/chest.06-2846

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  72 in total

1.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD.

Authors:  Bridget F Collins; David Ramenofsky; David H Au; Jun Ma; Jane E Uman; Laura C Feemster
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

3.  Obstructive Sleep Apnea with Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries.

Authors:  Peter Starr; Amitesh Agarwal; Gurinder Singh; Enshuo Hsu; Wei Zhang; Yong-Fang Kuo; Carl Boethel; Gulshan Sharma
Journal:  Ann Am Thorac Soc       Date:  2019-01

4.  Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD.

Authors:  Bridget F Collins; Laura C Feemster; Seppo T Rinne; David H Au
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

5.  Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

Authors:  Wouter van Dijk; Wan Tan; Pei Li; Best Guo; Summer Li; Andrea Benedetti; Jean Bourbeau
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

6.  The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control.

Authors:  Elizabeth A Bayliss; Patrick J Blatchford; Sophia R Newcomer; John F Steiner; Diane L Fairclough
Journal:  J Gen Intern Med       Date:  2011-01-04       Impact factor: 5.128

7.  The 2nd National COPD Readmissions Summit and Beyond: From Theory to Implementation.

Authors:  Kristen S Willard; Jamie B Sullivan; Byron M Thomashow; Catherine S Jones; Leonard Fromer; Barbara P Yawn; Alpesh Amin; Jean M Rommes; Rhonda Rotert
Journal:  Chronic Obstr Pulm Dis       Date:  2016-10-06

8.  Use of spirometry in the diagnosis of COPD: a qualitative study in primary care.

Authors:  Min J Joo; Lisa K Sharp; David H Au; Todd A Lee; Marian L Fitzgibbon
Journal:  COPD       Date:  2013-03-28       Impact factor: 2.409

Review 9.  Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend.

Authors:  Christopher M Blanchette; Nicholas J Gross; Pablo Altman
Journal:  Am Health Drug Benefits       Date:  2014-04

Review 10.  Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype.

Authors:  Xu Chen; Xiaomao Xu; Fei Xiao
Journal:  Front Med       Date:  2013-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.